Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 728939, 6 pages
http://dx.doi.org/10.1155/2014/728939
Research Article

Circumsporozoite Protein-Specific -Restricted CD8+ T Cells Mediate Protective Antimalaria Immunity in Sporozoite-Immunized MHC-I- Transgenic Mice

1HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, 455 First Avenue, New York, NY 10016, USA
2Department of Pathology, New York University School of Medicine, 545 First Avenue, New York, NY 10016, USA

Received 24 April 2014; Accepted 23 June 2014; Published 15 July 2014

Academic Editor: Mauricio Martins Rodrigues

Copyright © 2014 Jing Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Malaria, Fact Sheet No 94, WHO, Geneva, Switzerland, 2008.
  2. P. D. Crompton, S. K. Pierce, and L. H. Miller, “Advances and challenges in malaria vaccine development,” Journal of Clinical Investigation, vol. 120, no. 12, pp. 4168–4178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. F. Clyde, V. C. McCarthy, R. M. Miller, and R. B. Hornick, “Specificity of protection of man immunized against sporozoite induced falciparum malaria,” American Journal of the Medical Sciences, vol. 266, no. 6, pp. 398–403, 1973. View at Publisher · View at Google Scholar · View at Scopus
  4. R. W. Gwadz, A. H. Cochrane, V. Nussenzweig, and R. S. Nussenzweig, “Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites,” Bulletin of the World Health Organization, vol. 57, no. 1, pp. 165–173, 1979. View at Google Scholar · View at Scopus
  5. D. Herrington, J. Davis, E. Nardin et al., “Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals,” The American Journal of Tropical Medicine and Hygiene, vol. 45, no. 5, pp. 539–547, 1991. View at Google Scholar · View at Scopus
  6. S. L. Hoffman, L. M. L. Goh, T. C. Luke et al., “Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites,” Journal of Infectious Diseases, vol. 185, no. 8, pp. 1155–1164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Nussenzweig, J. Vanderberg, H. Most, and C. Orton, “Protective immunity produced by the injection of X-irradiated sporozoites of plasmodium berghei,” Nature, vol. 216, no. 5111, pp. 160–162, 1967. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Schofield, J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig, “γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites,” Nature, vol. 330, no. 6149, pp. 664–666, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. W. R. Weiss, M. Sedegah, R. L. Beaudoin, L. H. Miller, and M. F. Good, “CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 2, pp. 573–576, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Rodrigues, A.-S. Cordey, G. Arreaza et al., “CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria,” International Immunology, vol. 3, no. 6, pp. 579–585, 1991. View at Google Scholar · View at Scopus
  11. W. R. Weiss, J. A. Berzofsky, R. A. Houghten, M. Sedegah, M. Hollindale, and S. L. Hoffman, “A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei,” Journal of Immunology, vol. 149, no. 6, pp. 2103–2109, 1992. View at Google Scholar · View at Scopus
  12. G. Sano, J. C. R. Hafalla, A. Morrot, R. Abe, J. J. Lafaille, and F. Zavala, “Swift development of protective effector functions in naive CD8+ T cells against malaria liver stages,” Journal of Experimental Medicine, vol. 194, no. 2, pp. 173–179, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Epstein, K. Tewari, K. E. Lyke et al., “Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity,” Science, vol. 334, no. 6055, pp. 475–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Seder, L. Chang, M. E. Enama et al., “Protection against malaria by intravenous immunization with a non-replicating sporozoite vaccine,” Science, vol. 341, no. 6152, pp. 1359–1365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Tsuji and F. Zavala, “T cells as mediators of protective immunity against liver stages of Plasmodium,” Trends in Parasitology, vol. 19, no. 2, pp. 88–93, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Tsuji, “Re-evaluating the role of T cells for the development of T cell-based malaria vaccine,” Experimental Parasitology, vol. 126, pp. 421–425, 2010. View at Google Scholar
  17. J. Huang, X. Li, K. Kohno et al., “Generation of tissue-specific H-2Kd transgenic mice for the study of Kd-restricted malaria epitope-specific CD8+ T-cell responses in vivo,” Journal of Immunological Methods, vol. 387, no. 1-2, pp. 254–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Arun Kumar, G. Sano, S. Boscardin et al., “The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites,” Nature, vol. 444, no. 7121, pp. 937–940, 2006. View at Publisher · View at Google Scholar · View at Scopus